期刊
INFECTIOUS DISEASE CLINICS OF NORTH AMERICA
卷 23, 期 2, 页码 277-+出版社
W B SAUNDERS CO-ELSEVIER INC
DOI: 10.1016/j.idc.2009.01.004
关键词
Synergism; Combination antibiotic treatment; Beta-lactam; Aminoglycoside; Pseuodomonas aeruginosa; Meta-analysis; Systematic review
Interactions between antibiotic combinations predicted by in vitro studies are not consistently reflected in clinical trials. Beta-lactam-aminoglycoside combinations, synergistic in vitro, do not confer improved survival or cure and do not prevent breakthrough infections. These conclusions are derived from recent systematic reviews and meta-analyses of randomized, controlled trials. Often, pertinent clinical outcomes could not be assessed meaningfully in individual randomized trials, but their compilation leads to strong conclusions relating to outcomes that affect the individual patient. Systematic reviews have made possible the evidence-based use of antibiotic combinations.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据